These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 14670642)
1. Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection. Rosano GM; Vitale C; Silvestri A; Fini M Maturitas; 2003 Dec; 46 Suppl 1():S17-29. PubMed ID: 14670642 [TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
3. The relative effects of progesterone and progestins in hormone replacement therapy. Rosano GM; Sarais C; Zoncu S; Mercuro G Hum Reprod; 2000 Jun; 15 Suppl 1():60-73. PubMed ID: 10928419 [TBL] [Abstract][Full Text] [Related]
4. Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women. Shulman LP Am J Cardiol; 2002 Jun; 89(12A):47E-54E; discussion 54E-55E. PubMed ID: 12084405 [TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Crook D; Godsland IF; Wynn V Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933 [TBL] [Abstract][Full Text] [Related]
6. Estrogens and progestins in postmenopausal women: influence on lipid parameters and cardiovascular risk. Bruckert E; Turpin G Horm Res; 1995; 43(1-3):100-3. PubMed ID: 7721254 [TBL] [Abstract][Full Text] [Related]
7. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy. Rosano GM; Fini M Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270 [TBL] [Abstract][Full Text] [Related]
8. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys. Williams JK; Delansorne R; Paris J J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):219-24. PubMed ID: 9699876 [TBL] [Abstract][Full Text] [Related]
10. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment. Gungor F; Kalelioglu I; Turfanda A Angiology; 2009; 60(3):308-17. PubMed ID: 18505742 [TBL] [Abstract][Full Text] [Related]
11. How progestins influence the cardiovascular effect of hormone replacement therapy. Rosano GM; Mercuro G; Vitale C; Rossini P; Galetta P; Fini M Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():9-17. PubMed ID: 12227881 [TBL] [Abstract][Full Text] [Related]
12. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425 [TBL] [Abstract][Full Text] [Related]
13. Effects of androgens on haemostasis. Winkler UH Maturitas; 1996 Jul; 24(3):147-55. PubMed ID: 8844628 [TBL] [Abstract][Full Text] [Related]
14. The adverse effects of hormonal therapy. Bush TL Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of progestins on the circulating IGF-I system. Campagnoli C; AbbĂ C; Ambroggio S; Peris C Maturitas; 2003 Dec; 46 Suppl 1():S39-44. PubMed ID: 14670644 [TBL] [Abstract][Full Text] [Related]
16. [Progestogens, progesterone, coagulation and vascular tone]. Schved JF; Biron C Gynecol Obstet Fertil; 2002 May; 30(5):421-6. PubMed ID: 12087938 [TBL] [Abstract][Full Text] [Related]